Trial intelligence / Profile preview

Weipi Formula for Functional Dyspepsia

NCT06985524Enrolling by invitation

Sponsor
The Second Affiliated Hospital of Nanchang University
Start
Jan 2024
Primary completion
Dec 2026
Modality
HM (Herbal Medicine)
Countries
1
01

Overview

Randomised, double-blind trial in functional dyspepsia (FD) comparing Weipi Formula with Placebo (2 arms). Primary endpoint: Traditional Chinese Medicine Syndrome Scores at 2 weeks. Started Jan 2024; status: enrolling by invitation.

02

Drugs

Weipi Formula
03

Conditions

functional dyspepsia (FD)

Beyond the preview

Go deeper on NCT06985524.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06985524.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call